article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. Biogen’s failure should be a warning to other pharma companies.

Pharma 210
article thumbnail

What the latest DEA Proposed Rule Means for Telemedicine Prescribing of Controlled Substances

Nixon Gwilt Law

Notably, this rulemaking does not propose to implement the “special registration” for telemedicine providers the DEA has been promising since the Ryan Haight Act passed in 2009. Instead, it would create a new regulatory category of the “practice of telemedicine.” We will publish a second post shortly on that proposed rule and link it here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Value of Humans in a Tech-Driven World

PM360

Airways Flight 1549 in January 2009, when it hit a flock of geese, disabling both its engines. The best reps focus on patients, not prescriptions. The best reps focus on patients, not prescriptions. Sometimes the human element can make all the difference. They are focused on patient outcomes, not just patient onboarding.

Sales 52
article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records. Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.”

article thumbnail

Effective Pharma Ad Types & Stats

Pharma Marketing Network

“Direct-to-Consumer Advertising of Prescription Drugs.” “The Impact of Direct-to-Consumer Advertising on Prescription Drug Spending.” ” Pharmacy and Therapeutics, 2009. . ” Pharmacy and Therapeutics, 2009. . “Pharmaceutical Advertising Spending in the US.” ” U.S.

Pharma 52
article thumbnail

Exforge antitrust settlement caps Novartis’ year of legal disputes

Pharmaceutical Technology

Ex-Novartis sales representative Steven Camburn filed a whistleblower case that claimed Novartis had paid doctors up to $3,500 to participate in educational speaker programs to increase the promotion and prescription of Gilenya. However, Novartis did not get the same reception while facing similar allegations in Greece.

article thumbnail

Frontiers Health Steering Committee spotlight – Paul Tunnah

pharmaphorum

Instead, he shifted to consulting and, after a period of time, the launch of pharmaphorum in 2009. “[My] Tunnah realised, in fact, that that communicative passion lay within himself and wasn’t satisfied by academic work. This] enabled people to access that in a way they hadn’t done before.

Pharma 98